Phosphate Retention: Causes, Symptoms & Treatment
Phosphate retention occurs when the body accumulates excess phosphate in the blood, most commonly due to kidney disease. It can lead to serious complications such as vascular calcification.
Things worth knowing about "Phosphate retention"
Phosphate retention occurs when the body accumulates excess phosphate in the blood, most commonly due to kidney disease. It can lead to serious complications such as vascular calcification.
What is Phosphate Retention?
Phosphate retention is a condition in which phosphate accumulates in the bloodstream because the kidneys are no longer able to excrete it adequately. Phosphate is an essential mineral required for bone formation, energy metabolism, and numerous cellular processes. In healthy individuals, the kidneys precisely regulate blood phosphate levels. When kidney function is impaired, blood phosphate levels rise – a condition that can progress to hyperphosphatemia (elevated blood phosphate levels) in advanced stages.
Causes
The most common cause of phosphate retention is chronic kidney disease (CKD). As kidney function declines, less phosphate can be excreted through the urine. Other causes include:
- Acute kidney failure: sudden loss of the kidney's filtration capacity
- Hypoparathyroidism: reduced production of parathyroid hormone (PTH), which normally promotes phosphate excretion
- High phosphate intake: excessive consumption of phosphate-rich foods or phosphate additives in processed foods
- Rhabdomyolysis: breakdown of muscle tissue releasing large amounts of phosphate
- Tumor lysis syndrome: massive cell destruction during cancer treatment
Symptoms
In early stages, phosphate retention often causes no noticeable symptoms. As severity increases, the following symptoms may occur:
- Itching (pruritus): caused by deposition of calcium-phosphate crystals in the skin
- Bone pain and weakness: due to disruption of calcium and vitamin D metabolism
- Muscle cramps: resulting from altered electrolyte balance
- Vascular calcifications: increased risk of cardiovascular disease and stroke
- Cardiovascular complications: increased risk of heart failure and arrhythmias
Diagnosis
Phosphate retention is typically diagnosed through blood tests. The following parameters are assessed:
- Serum phosphate: normal range in adults approximately 0.81–1.45 mmol/l; values above this indicate hyperphosphatemia
- Serum calcium: often reduced when phosphate is elevated
- Parathyroid hormone (PTH): frequently elevated as a response to low calcium
- Creatinine and GFR: to assess kidney function
- Vitamin D (25-OH-D3): often reduced in kidney disease
Treatment
Treatment of phosphate retention depends on the underlying cause and the severity of the condition.
Dietary Measures
A low-phosphate diet is a cornerstone of treatment. Patients are advised to reduce their intake of phosphate-rich foods such as dairy products, whole grains, legumes, and processed foods containing phosphate additives (e.g., E338–E341, E450–E452).
Phosphate Binders
Phosphate binders are medications that bind phosphate in the gut and prevent its absorption. They are taken with meals and include:
- Calcium-based phosphate binders: e.g., calcium carbonate, calcium acetate
- Non-calcium phosphate binders: e.g., sevelamer, lanthanum carbonate
- Iron-based phosphate binders: e.g., sucroferric oxyhydroxide
Dialysis
In patients with end-stage kidney disease, hemodialysis or peritoneal dialysis can help remove excess phosphate from the blood. However, the effectiveness is limited, making dietary measures and phosphate binders still necessary.
Treatment of Underlying Conditions
Optimal management of the underlying kidney disease and control of secondary hyperparathyroidism using vitamin D analogues (e.g., calcitriol, paricalcitol) or calcimimetics (e.g., cinacalcet) are also important treatment options.
References
- Kidney Disease: Improving Global Outcomes (KDIGO) - CKD-MBD Update Guideline 2017: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney International Supplements, 7(1), 1–59.
- Moe, S.M. (2008). Disorders involving calcium, phosphorus, and magnesium. Primary Care: Clinics in Office Practice, 35(2), 215–237.
- National Kidney Foundation (NKF): KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. American Journal of Kidney Diseases, 42(4 Suppl 3), S1–S202, 2003.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.